Minor contribution of mutations at <it>iniA </it>codon 501 and <it>embC-embA </it>intergenic region in ethambutol-resistant clinical <it>Mycobacterium tuberculosis </it>isolates in Kuwait

<p>Abstract</p> <p>Background</p> <p>Ethambutol (EMB) is a first-line drug for the treatment of tuberculosis (TB). Resistance to EMB in <it>Mycobacterium tuberculosis </it>isolates is mediated by mutations in several genes involved in arabinan synthesis nota...

Full description

Bibliographic Details
Main Authors: Ahmad Suhail, Jaber Al-Anoud, Mokaddas Eiman
Format: Article
Language:English
Published: BMC 2009-01-01
Series:Annals of Clinical Microbiology and Antimicrobials
Online Access:http://www.ann-clinmicrob.com/content/8/1/2